When is a pandemic “over?” Did biotech over-SPAC? And what can’t be CRISPR’d?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Heidi Tworek, a professor at the University of British Columbia and expert on public health communication, joins us to discuss President Biden’s declaration that “the pandemic is over” and how leaders around the world are talking about Covid-19 as it enters its third year. We’ll also discuss the latest news in the life sciences, including the twilight of the SPAC boom, the coming evolution of genome editing, and the next big trial in Alzheimer’s disease.
mRNA became mainstream with Covid vaccines. But the technology’s therapeutic potential is huge.
mRNA has proven itself in Covid-19 vaccines. But that’s just the beginning. How can we use mRNA to take health care to the next level — to potentially cure neurological disorders and the deadliest of cancers? While scientists explore those questions, biopharma must make some adjustments to pave the road to success. Read the article here.
Post Comment
No comments